7z5t
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal Structure of botulinum neurotoxin A2 cell binding domain== | ==Crystal Structure of botulinum neurotoxin A2 cell binding domain== | ||
| - | <StructureSection load='7z5t' size='340' side='right'caption='[[7z5t]]' scene=''> | + | <StructureSection load='7z5t' size='340' side='right'caption='[[7z5t]], [[Resolution|resolution]] 1.63Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z5T OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z5T FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[7z5t]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z5T OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z5T FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z5t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z5t OCA], [https://pdbe.org/7z5t PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z5t RCSB], [https://www.ebi.ac.uk/pdbsum/7z5t PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z5t ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.63Å</td></tr> |
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z5t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z5t OCA], [https://pdbe.org/7z5t PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z5t RCSB], [https://www.ebi.ac.uk/pdbsum/7z5t PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z5t ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/K4GGE0_CLOBO K4GGE0_CLOBO] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Botulinum neurotoxins (BoNT) are a group of clostridial toxins that cause the potentially fatal neuroparalytic disease botulism. Although highly toxic, BoNTs are utilized as therapeutics to treat a range of neuromuscular conditions. Several serotypes (BoNT/A-/G, /X) have been identified with vastly differing toxicological profiles. Each serotype can be further sub-categorised into subtypes due to subtle variations in their protein sequence. These minor changes have been attributed to differences in both the duration of action and potency for BoNT/A subtypes. BoNTs are composed of three domains-a cell-binding domain, a translocation domain, and a catalytic domain. In this paper, we present the crystal structures of the botulinum neurotoxin A2 cell binding domain, both alone and in complex with its receptor ganglioside GD1a at 1.63 and 2.10 A, respectively. The analysis of these structures reveals a potential redox-dependent Lys-O-Cys bridge close to the ganglioside binding site and a hinge motion between the HCN and HCC subdomains. Furthermore, we make a detailed comparison with the previously reported HC/A2:SV2C structure for a comprehensive structural analysis of HC/A2 receptor binding. | ||
| + | |||
| + | Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain.,Gregory KS, Mahadeva TB, Liu SM, Acharya KR Toxins (Basel). 2022 May 19;14(5). pii: toxins14050356. doi:, 10.3390/toxins14050356. PMID:35622602<ref>PMID:35622602</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7z5t" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Botulinum neurotoxin 3D structures|Botulinum neurotoxin 3D structures]] | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Clostridium botulinum]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Acharya KR]] | [[Category: Acharya KR]] | ||
Current revision
Crystal Structure of botulinum neurotoxin A2 cell binding domain
| |||||||||||
